发现了结构约束的ALK2抑制剂
Héctor González-Álvarez1,2, Deeba Ensan1,2, Tao Xin1
1Drug Discovery Program, Ontario Institute for Cancer Research, 661 University Avenue, MaRS Centre, West Tower, Toronto, Ontario M5G 0A3, Canada.
研究人员开发了新型ALK2抑制剂,其强度和选择性得到改善,用于治疗扩散内在庞丁质瘤 (DIPG). 这些化合物对DIPG的未来治疗发展充满希望.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 扩散内在庞丁质瘤 (DIPG) 仍然是一个毁灭性的儿科脑瘤,治疗选择有限.
- 几十年的研究已经在DIPG患者的治疗结果中取得了微小的改善.
- 针对异常信号通路,例如涉及ALK2的信号通路,是开发新癌症疗法的关键策略.
研究的目的:
- 设计,合成和评估基于M4K2009的脚手架修改的新型ALK2抑制剂.
- 探索硬化策略对抑制剂强度和选择性的影响.
- 确定用于治疗DIPG的潜在候选药物.
主要方法:
- 新型以太结合和氨基结合受约束ALK2抑制剂的合成.
- 对ALK2.2的抑制剂功能的体外评估.
- 对相关激酶的选择性评估,例如ALK5.5.
- 在体内初步的药理动力学研究,包括血脑屏障的透.
主要成果:
- 发现了ALK2.2的强有力的以太连接抑制剂 (M4K2308,M4K2281) 和氨基连接抑制剂 (M4K2304,M4K2306).
- 与参考化合物相比,对ALK2的优越功效的证明.
- M4K2304和M4K2306对ALK2比ALK5.5具有异常的选择性.
- 在受限制的支架中观察到有利的体内药理动力学特征,包括血脑屏障的透.
结论:
- 开发出了具有增强功效和选择性的新型受约束ALK2抑制剂.
- 这些化合物代表了DIPG治疗开发的有希望的新化学空间.
- 需要在正方形DIPG模型中进行进一步的优化和评估.
更多相关视频
11:11Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Alkynes to Aldehydes and Ketones: Hydroboration-Oxidation
One of the convenient methods for the preparation of aldehydes and ketones is via hydration of alkynes. Hydroboration-oxidation of alkynes is an indirect hydration reaction in which an alkyne is treated with borane followed by oxidation with alkaline peroxide to form an enol that rapidly converts into an aldehyde or a ketone. Terminal alkynes form aldehydes, whereas internal alkynes give ketones as the final product.
Electrophilic Addition to Alkynes: Halogenation
Halogenation is another class of electrophilic addition reactions where a halogen molecule gets added across a π bond. In alkynes, the presence of two π bonds allows for the addition of two equivalents of halogens (bromine or chlorine). The addition of the first halogen molecule forms a trans-dihaloalkene as the major product and the cis isomer as the minor product. Subsequent addition of the second equivalent yields the tetrahalide.
Ligand Binding and Linkage
Conformations of Cycloalkanes
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Enzyme Inhibition
